Showing results (111-120 of 129) with videos related to
Sort By:
Pageof 13
JAMA Oncology|January 13, 2018
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical TrialLuca Gianni, Mauro Mansutti, Antonio Anton, et al.NPJ Genomic Medicine|January 17, 2025
Germline structural variant as the cause of Lynch Syndrome in a family from EcuadorGemma Llargués-Sistac, Laia Bonjoch, Jenifer Muñoz, et al.ACS Infectious Diseases|September 14, 2016
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosisThulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, et al.Cancers|November 27, 2024
Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter StudyJoan Llach, Irina Luzko, Julie Earl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2017
Long-Term Follow-Up of the Intergroup Exemestane StudyJames P Morden, Isabel Alvarez, Gianfilippo Bertelli, et al.Diabetologia|January 28, 2016
PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitusJosé Manuel Mellado-Gil, Carmen María Jiménez-Moreno, Alejandro Martin-Montalvo, et al.Journal of Neurology|March 2, 2025
Late-onset vestibulocerebellar ataxia: clinical and genetic studies in a long follow-up series of 50 patientsDavid Genís, Berta Alemany, David Pellerin, et al.The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.Leukemia & Lymphoma|October 9, 2021
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana LinfomiAnnalisa Arcari, Lucia Morello, Daniele Vallisa, et al.British Journal of Haematology|November 9, 2018
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 studyEmilio Iannitto, Monica Bellei, Sandy Amorim, et al.Pageof 13